Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.


Investor type Government Office


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 913
Average round size
The average size of a deal this fund participated in
Portfolio companies 730
Rounds per year 91.30
Lead investments 159
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 87
Key employees 62
Stages of investment
Early Stage Venture
Private Equity

Areas of investment

  • Software
  • Biotechnology
  • Health Care
  • Information Technology
  • SaaS

In 2012 was created Bpifrance, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the Maisons-alfort. The fund was located in Europe if to be more exact in France.

The overall number of key employees were 57.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Bpifrance, startups are often financed by Xavier Niel, Sofinnova Partners, Iris Capital. The meaningful sponsors for the fund in investment in the same round are Omnes Capital, Hi Inov - Dentressangle, Elaia. In the next rounds fund is usually obtained by Alven Capital, Omnes Capital, Auriga Partners.

Among the most successful fund investment fields, there are SaaS, Health Care. Among the most popular portfolio startups of the fund, we may highlight Doctolib, Symphony Communication Services Holdings, ManoMano. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - France. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.

Opposing the other organizations, this Bpifrance works on 18 percentage points less the average amount of lead investments. The important activity for fund was in 2018. The typical startup value when the investment from Bpifrance is 100-500 millions dollars. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 25-48 investment rounds annually. The higher amount of exits for fund were in 2019. Speaking about the real fund results, this Corporate Investor is 3 percentage points more often commits exit comparing to other organizations.

Read more

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Dust Mobile

$14M23 Nov 2022 City of Brussels, Belgium


Information Technology
$7M21 Nov 2022 Grenoble, Rhone-Alpes, France


$295M02 Nov 2022 Grenoble, Rhone-Alpes, France


Digital Marketing
$3M28 Oct 2022 Paris, Ile-de-France, France


Freight Service
Supply Chain Management
$47M24 Oct 2022 Paris, Ile-de-France, France


Artificial Intelligence
Service Industry
$26M20 Oct 2022 Paris, Ile-de-France, France


Artificial Intelligence
Machine Learning
Quantum Computing
$35M19 Oct 2022 Paris, Ile-de-France, France

Homa Games

$121M12 Oct 2022 Paris, Ile-de-France, France


Financial Services
Financial Software
Other Financial Services
Trading Platform
$40M06 Oct 2022 Berkeley, California, United States
Corporate learning platform 360Learning raises $200 million

– 360Learning, a French e-learning company, raised $50m funding.
– The round was led by Bpifrance’s Large Venture fund and joined by XAnge and Educapital.
– Existing investors also participated in the round.
– The company plans to hire more people, expand to new markets and make some acquisitions.

Provepharm Life Solution Raises €120M in Funding

– Provepharm Life Solutions, a Marseille-based pharmaceutical company that finds new applications for known molecules.
– The company raised €120M in funding.
Tikehau Capital will provide the funds joining the group’s pool of banking investors, including Société Générale, BNP Paribas, Banque Populaire Méditerranée, Crédit Agricole Alpes Provence and Bpifrance.
– The new investment will be used to consolidate its position as an international and independent pharmaceutical group, specifically by hiring new staff in France and the United States, and increasing the size of its laboratories in Marseille.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Bpifrance?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: